SN
Santen Pharmaceutical Co., Ltd.
SNPHY · OTC
$11.09 -3.06% (-$0.35)
1M -10.56%
Market Cap ¥574.7B
P/E Ratio 14.61x
Div. Yield 1.95%
ROE 13.63%
Bulios Fair Price
$13.42
21.0% upside
Trenutna cena
$11.09
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SNPHY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
84 /100
Cheap EV/EBITDA 7.97x
P/S 1.94x
P/B 1.93x
Growth
58 /100
Stable FCF growth 45.73%
Book val. growth 0.48%
Rev. growth 3.48%
Profitability
78 /100
Strong Net margin 13.26%
Op. margin 15.68%
FCF margin 12.19%
Quality
65 /100
Average ROE 13.63%
ROA 9.52%
Asset turnover 0.72x
Debt
100 /100
Low Current ratio 2.82x
Int. coverage 23.47x
Net debt/EBITDA -0.71x
Stability
40 /100
Moderate Rev. volatility 4.45%
EPS volatility 149.18%
Profitable years 3
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SNPHY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Takeshi Ito
Employees
3,968
Headquarters
Kita
Prihajajoči dogodki
29 SEP.
Ex-Dividend
Ex-dividend date
30 NOV.
Dividend Payment
Datum plačila